Jörn M. Schattenberg, MD - Cases in Contemporary MASH Management: Expert Insights on the Practical Integration of Disease-Specific Pharmacotherapy

Visit https://www.peervoice.com/NVE860 to view the entire programme with slides. After completing “Jörn M. Schattenberg, MD - Cases in Contemporary MASH Management: Expert Insights on the Practical Integration of Disease-Specific Pharmacotherapy”, participants will be able to: Evaluate current evidence and practice guidance for use of liver-directed pharmacotherapy for management of metabolic dysfunction-associated steatohepatitis (MASH); Identify individuals with non-cirrhotic MASH and moderate to advanced (F2-F3) fibrosis who may benefit from timely initiation of disease-specific pharmacotherapy; Design comprehensive management plans for individuals with MASH and fibrosis that appropriately integrate liver-directed pharmacotherapy, lifestyle modifications, and comorbidity management; and Apply recommended strategies to monitor individuals receiving disease-specific pharmacotherapy for MASH.

Listen